Assessing Whether Cytosorbents Corp (NASDAQ: CTSO) Is Over- Or Undervalued

Skylands Capital LLC has recently announced that it has increased stake in Cytosorbents Corp (NASDAQ:CTSO) by 5.41%. After grabbing 2.94 million shares, the institutional investor is now in possession of 0.15 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.63% having worth around $3.53 million. Moreover, Neuberger […]